[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$1226m Graphic](https://lunarcrush.com/gi/w:26/t:$1226m.png) $1226m

Zydus Lifesciences gets USFDA approval for Celecoxib Capsules, and HDFC Life Insurance reports strong Q1 results.

### About $1226m
A financial topic related to market analysis and social media engagement.  

### Insights [#](/topic/$1226m/insights)
- $1226m creators is up XXXXX% from the previous month.
- $1226m mentions is up XXXXX% from the previous month.

### Engagements: XX [#](/topic/$1226m/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1226m/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$1226m/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XX -XX%  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-07-12  
**1-Year Low**: X on 2025-07-06  

| Social Network | X  | Reddit |
| -------------- | -  | ------ |
| Engagements    | XX | X      |
  

  
  
### Mentions: X [#](/topic/$1226m/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1226m/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$1226m/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: XX +40%  
**1 Month**: XX +45%  
**1-Year High**: XX on 2025-05-30  
**1-Year Low**: X on 2025-05-01  

| Social Network | X | Reddit |
| -------------- | - | ------ |
| Mentions       | X | X      |
  

  
  
### Creators: X [#](/topic/$1226m/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1226m/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$1226m/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $1226m in the last XX hours which is down XX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +40%  
**1 Month**: XX +48%  
**1-Year High**: XX on 2025-05-30  
**1-Year Low**: X on 2025-05-01  
  
  
### Sentiment: % [#](/topic/$1226m/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$1226m/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$1226m/time-series/sentiment.tsv)  
**Current Value**: %  
**Daily Average**: XX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-05-30  
**1-Year Low**: XX% on 2025-06-28  

**Top assets mentioned**
In the posts about $1226m in the last XX hours

[Rai Reflex Index (RAI)](/topic/$rai)
[SuperVerse (SUPER)](/topic/$super)
[Ethereum (ETH)](/topic/ethereum)
[SuperVerse (SUPER)](/topic/superverse)
[Morphware (XMW)](/topic/$xmw)
[Destra Network (DSYNC)](/topic/$dsync)
[PAAL AI (PAAL)](/topic/$paal)
[NEURALAI (NEURAL)](/topic/$neural)
[Vertical AI (VERTAI)](/topic/$vertai)
[ApeSwap (BANANA)](/topic/$banana)

**Top topics mentioned**
In the posts about $1226m in the last XX hours

[$zyduslifebo](/topic/$zyduslifebo), [coins gaming](/topic/coins-gaming), [coins solana ecosystem](/topic/coins-solana-ecosystem), [oxo](/topic/oxo), [banana](/topic/banana), [vertai](/topic/vertai), [neural](/topic/neural), [paal](/topic/paal), [dsync](/topic/dsync), [xmw](/topic/xmw), [$80m](/topic/$80m), [$rai](/topic/$rai), [$679m](/topic/$679m), [$oxo](/topic/$oxo), [$446m](/topic/$446m), [$792m](/topic/$792m), [$114m](/topic/$114m), [$295m](/topic/$295m), [$1340m](/topic/$1340m), [$415m](/topic/$415m), [$3150m](/topic/$3150m), [$super](/topic/$super), [ethereum](/topic/ethereum), [coins layer 1](/topic/coins-layer-1), [superverse](/topic/superverse), [coins made in usa](/topic/coins-made-in-usa), [coins inj](/topic/coins-inj), [$xmw](/topic/$xmw), [coins ai agents](/topic/coins-ai-agents), [$dsync](/topic/$dsync), [coins depin](/topic/coins-depin), [$paal](/topic/$paal), [coins base ecosystem](/topic/coins-base-ecosystem), [coins ai](/topic/coins-ai), [coins defai](/topic/coins-defai), [$neural](/topic/$neural), [coins bittensor ecosystem](/topic/coins-bittensor-ecosystem), [$vertai](/topic/$vertai), [$banana](/topic/$banana), [coins defi](/topic/coins-defi), [coins bsc](/topic/coins-bsc), [coins exchange tokens](/topic/coins-exchange-tokens), [coins arbitrum](/topic/coins-arbitrum), [$hashai](/topic/$hashai), [rai reploy](/topic/rai-reploy), [coins meme](/topic/coins-meme), [united states](/topic/united-states), [$145m44](/topic/$145m44), [$386m](/topic/$386m), [$89m](/topic/$89m), [$143m](/topic/$143m), [mufasa](/topic/mufasa), [china](/topic/china), [1b](/topic/1b), [100m](/topic/100m), [founders fund](/topic/founders-fund), [$273m](/topic/$273m), [$1b](/topic/$1b), [spark capital](/topic/spark-capital), [$100m](/topic/$100m), [seed funding](/topic/seed-funding), [$70m](/topic/$70m), [coins sports](/topic/coins-sports), [$13b](/topic/$13b), [executive director](/topic/executive-director), [$vrc](/topic/$vrc), [$hdfclifebo](/topic/$hdfclifebo), [life insurance](/topic/life-insurance), [insurance](/topic/insurance), [hdfc life](/topic/hdfc-life), [approved](/topic/approved), [stocks](/topic/stocks), [asts](/topic/asts), [$07m](/topic/$07m), [$113b](/topic/$113b), [$164b](/topic/$164b), [market cap](/topic/market-cap), [$rklb](/topic/$rklb), [$asts](/topic/$asts), [$151k](/topic/$151k), [$mplx](/topic/$mplx), [metaplex](/topic/metaplex), [mplx](/topic/mplx), [stocks energy](/topic/stocks-energy)

### Top Social Posts [#](/topic/$1226m/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"4 Zydus Lifesciences Gets USFDA final approval for Celecoxib Capsules. U.S. market size: $122.6M. ✅ #Zydus #USFDA #Pharma X Hathway Cable Q1 Net Profit up XX% YoY to XX Cr. Revenue at XXX Cr vs XXX Cr YoY. ✅ #Hathway #Cable #Earnings"  
[@Vyom_akhani](/creator/x/Vyom_akhani) on [X](/post/tweet/1945355123422847020) 2025-07-16 05:29:39 UTC XXX followers, XX engagements


"👉Stocks In Focus (16/07/25) Zydus Lifesciences: USFDA approved Celecoxib Capsules; US sales $122.6M. HDFC Life Insurance: Q1 Net Profit XXXX billion vs XXXX billion (YoY) Q1 Net Premium Income XXX B vs XXXXX B (YoY) Q1 VNB at XXXX billion vs XXX billion (YoY) Q1 Total APE XXXXX billion vs XXXXX billion (YoY) Q1 New Business Premium at XXXXX B vs 64B (YoY). Brigade Enterprises: Buzzworks expands workspace by 50000 sqft in Hyderabad. Dixon Technologies: To acquire XX% of Q Tech India (camera/fingerprint modules) and JV with Chongqing Yuhai for precision components (laptops/mobiles). Geojit"  
[@GOGINENIlive](/creator/x/GOGINENIlive) on [X](/post/tweet/1945310132709286061) 2025-07-16 02:30:52 UTC XXX followers, XX engagements


"✅ Zydus Lifesciences gets final USFDA approval for Celecoxib Capsules 💊 Used for pain & inflammation 💵 US sales: $122.6M (as per IQVIA) 🌎 Strengthens Zydus US generics portfolio #USFDA #Pharma #Generics 🔁Repost ❤Like 📲 Follow @pesopeanut for pharma approvals & insights"  
[@pesopeanut](/creator/x/pesopeanut) on [X](/post/tweet/1945096107853332816) 2025-07-15 12:20:24 UTC XXX followers, XX engagements